Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
2019 ◽
Vol 14
(5)
◽
pp. 867-875
◽
Yi-Long Wu
◽
Shun Lu
◽
Ying Cheng
◽
Caicun Zhou
◽
Jie Wang
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 6105-6105
A. G. Sacher
◽
N. B. Leighl
2011 ◽
Vol 66
(Suppl 4)
◽
pp. A41-A41
◽
D. Ferry
◽
L. J. Billingham
◽
H. W. Jarrett
◽
D. Dunlop
◽
J. Thompson
◽
...
Yi-Long Wu
◽
Shun Lu
◽
Ying Cheng
◽
Caicun Zhou
◽
Jie Wang
◽
...
2007 ◽
Vol 57
(6)
◽
pp. 501
Hyobin Seo
◽
Moon Hee Han
◽
Bae Ju Kwon
◽
So Hyang Im
◽
Cheolkyu Jung
◽
...
2019 ◽
Vol 30
(12)
◽
pp. 1950-1958
◽
C. Morizane
◽
T. Okusaka
◽
J. Mizusawa
◽
H. Katayama
◽
M. Ueno
◽
...
2017 ◽
Vol 61
(1)
◽
pp. 435-457
◽
Gordon K. Wilcock
◽
Serge Gauthier
◽
Giovanni B. Frisoni
◽
Jianping Jia
◽
Jiri H. Hardlund
◽
...
Close
Export Citation Format
Close
Share Document
Close